O'HEERON PETE (CHIEF EXECUTIVE OFFICER) purchased 0.9% of their position (51.50K shares) of FIBROBIOLOGICS, INC. on the open market
Open‑market purchase worth $19.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/4/2026ACC: 0001493152-26-008903
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
+51.50K
Net shares
Net buyer
$19.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
51.50K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+17.43K
Price / share
$0.35
Trade value
$6.15K
% of position
0.3%
3/2/2026
5.91M→5.92M
Common Stock
Direct
Shares
+18.20K
Price / share
$0.41
Trade value
$7.37K
% of position
0.3%
3/3/2026
5.92M→5.94M
Common Stock
Direct
Shares
+15.87K
Price / share
$0.38
Trade value
$6.01K
% of position
0.3%
3/4/2026
5.94M→5.96M
Total
Net shares
+51.50K
Net value
$19.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | P · Purchase | +17.43K | $0.35 | $6.15K | 0.3% | 5.91M | 5.92M |
| Common Stock Direct | 3/3/2026 | P · Purchase | +18.20K | $0.41 | $7.37K | 0.3% | 5.92M | 5.94M |
| Common Stock Direct | 3/4/2026 | P · Purchase | +15.87K | $0.38 | $6.01K | 0.3% | 5.94M | 5.96M |
| Total | +51.50K | $19.53K | ||||||
Derivative Transactions0
No derivative transactions reported